{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:39:12Z","timestamp":1761662352836},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.clineuro.2006.01.009","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:46Z","timestamp":1145468566000},"page":"54-57","source":"Crossref","is-referenced-by-count":27,"title":["Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt\u2013Jakob disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Chiung-Chih","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julene K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aissa","family":"Haman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2006.01.009_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.55.4.514","article-title":"14-3-3 testing in diagnosing Creutzfeldt\u2013Jakob disease","volume":"55","author":"Lemstra","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2006.01.009_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.clineuro.2006.01.009_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2006.01.009_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/WNL.56.11.1528","article-title":"CSF detection of the 14-3-3 protein in unselected patients with dementia","volume":"56","author":"Burkhard","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2006.01.009_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt\u2013Jakob disease","volume":"60","author":"Geschwind","year":"2003","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.clineuro.2006.01.009_bib6","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.55.9.1396","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"55","author":"Chapman","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2006.01.009_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s004150200074","article-title":"14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis","volume":"249","author":"de Seze","year":"2002","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.clineuro.2006.01.009_bib8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.54.7.1539","article-title":"Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy","volume":"54","author":"Hernandez Echebarria","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2006.01.009_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.57.4.722","article-title":"14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis","volume":"57","author":"Martinez-Yelamos","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2006.01.009_bib10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/1531-8249(199911)46:5<774::AID-ANA14>3.0.CO;2-N","article-title":"Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders","volume":"46","author":"Saiz","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2006.01.009_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000008054","article-title":"The 14-3-3 protein detectable in the cerebrospinal fluid of patients with Prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture","volume":"41","author":"Satoh","year":"1999","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.clineuro.2006.01.009_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/01.wnl.0000196440.00297.67","article-title":"First symptom in sporadic Creutzfeldt\u2013Jakob disease","volume":"66","author":"Rabinovici","year":"2006","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.clineuro.2006.01.009_bib13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2006.01.009_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.clineuro.2006.01.009_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.410360419","article-title":"Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy","volume":"36","author":"Nemni","year":"1994","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.clineuro.2006.01.009_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1468-1331.2003.00629.x","article-title":"Tremor of the mouth floor and anti-glutamic acid decarboxylase autoantibodies","volume":"10","author":"Vianello","year":"2003","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2006.01.009_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.33549\/physiolres.930485","article-title":"Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus","volume":"53","author":"Barova","year":"2004","journal-title":"Physiol Res"},{"issue":"6","key":"10.1016\/j.clineuro.2006.01.009_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.60.6.803","article-title":"Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt\u2013Jakob disease, laboratory standards, and quantitation","volume":"60","author":"Aksamit","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clineuro.2006.01.009_bib19","unstructured":"WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. World Health Organization: emerging and other communicable diseases, surveillance and control. Geneva; 1998."},{"key":"10.1016\/j.clineuro.2006.01.009_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","article-title":"Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt\u2013Jakob disease","volume":"I63","author":"Shiga","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2006.01.009_bib21","first-page":"1551","article-title":"Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt\u2013Jakob disease: high sensitivity and specificity for diagnosis","volume":"26","author":"Young","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.clineuro.2006.01.009_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0","article-title":"Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase","volume":"46","author":"Ishida","year":"1999","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.clineuro.2006.01.009_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2006.01.009_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","article-title":"Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity","volume":"61","author":"Rakocevic","year":"2004","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.clineuro.2006.01.009_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nn1348","article-title":"Adapter protein 14-3-3 is required for a presynaptic form of LTP in the cerebellum","volume":"7","author":"Simsek-Duran","year":"2004","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.clineuro.2006.01.009_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.57.4.728","article-title":"Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt\u2013Jakob disease","volume":"57","author":"Aksamit","year":"2001","journal-title":"Neurology"},{"issue":"Pt 1","key":"10.1016\/j.clineuro.2006.01.009_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/122.1.27","article-title":"Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders","volume":"122","author":"Dalmau","year":"1999","journal-title":"Brain"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846706000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846706000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:13:39Z","timestamp":1683432819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846706000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0303846706000138"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2006.01.009","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}